|
Session
Cross Platform Data Acquisition and Biological Analysis in the Drug Discovery Process
Matthew Frome, Bioinformatics Business Development Manager, Amersham Biosciences
Track: Discovery
Date: Wednesday, January 30
Time: 11:15am
- 12:00pm
Location: Canyon I
The past decade has seen dramatic progress in the development of factory
scale life science and drug development technologies, including DNA
sequencing, genotyping, gene expression and proteomics. These new
approaches and technologies are enabling researchers to conduct experiments
that will generate a tremendous amount of data. Additionally, researchers
are increasingly interested in understanding the biological relationships
between the various technologies. However, technological advancements in
Laboratory Information Management Systems (LIMS) have not kept pace. Novel,
effective, and flexible, workflow-based laboratory information management
systems are critical to both the success of each individual high-throughput
environment, but perhaps more critical to the cross platform biological
analysis in the drug discovery process.
Amersham Pharmacia Biotech, in partnership with Cimarron Software has
developed a family of workflow-based software products that addresses the
challenges of managing genetic and DNA-based information for the gene and
drug discovery processes. The Laboratory Workflow System (LWS) will
accelerate the creation, modification, automation, and re-use of laboratory
data collection and provide a framework for cross platform analysis
activities. The LWS technology is capable of delivering laboratory and
analysis workflow systems that are highly configurable to meet the exact
needs of each clients's environment.
|